Why the study?
Are mean platelet volume and platelet count altered in patients with Alzheimer's or Parkinson's disease compared to healthy controls?
Are mean platelet volume and platelet count altered in patients with Alzheimer's or Parkinson's disease compared to healthy controls?
Answers are grounded in this paper and cite their sources.
Mean platelet volume is elevated in Parkinson's disease compared to Alzheimer's disease and healthy controls, suggesting potential platelet dysfunction.
Platelets induce chronic inflammation which is a key step in atherosclerosis and may be involved in the progression of neurodegenerative diseases (NDD). We aimed to measure the mean platelet volume (MPV) and platelet count (PLC) in NDD patients. The present study was designed to investigate the platelet function by measuring MPV and PLC in NDD. A total of 182 outpatients with Alzheimer's (AD) or Parkinson's diseases (PD) were included. The control group consisted of 104 healthy subjects. Platelet count was similar between groups. MPV values of PD patients were higher than those of AD patients and controls (P < 0.001). MPV correlated negatively with Heohn and Yahr scale (HYS) score (P < 0.001). Increased MPV in patients with PD may point to a platelet dysfunction. High-grade inflammation presents with low levels of MPV as seen in PD patients with high HYS scores.
No takes yet. Share an insight, caveat, or question.
Koçer et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: